Abstract
Get full access to this article
View all access options for this article.
References
1.
Engin
M
Tatlı
AB
. Letter: Trefoil factor-3 and peripheral artery disease: Reason or result? Angiology . 2024 ;33197241256161 .
2.
Pesau
G
Zierfuss
B
Hoebaus
C
Koppensteiner
R
Schernthaner
GH
. Serum trefoil factor-3 predicts survival in peripheral artery disease . Angiology . 2024 ;33197241230973 .
3.
Webster
AC
Nagler
EV
Morton
RL
Masson
P
. Chronic kidney disease . Lancet . 2017 ;389 :1238 -1252 .
4.
Bujak
M
Bujak
IT
Sobočanec
S
, et al. Trefoil factor 3 deficiency affects liver lipid metabolism . Cell Physiol Biochem . 2018 ;47 :827 -841 .
5.
Berger
JS
Abramson
BL
Lopes
RD
, et al. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: insights from the EUCLID trial . Vasc Med . 2018 ;23 :523 -530 .